Bioprocessing Sponsored by MilliporeSigma
Medivir, SciLifeLab partner on SARS-CoV-2 inhibitors
Medivir, a Swedish pharmaceutical company, is partnering with SciLifeLab, a Swedish national research laboratory, to leverage their drug discovery and development platform to find potential inhibitors of SARS-CoV-2.
Dragonfly, Bristol Myers Squibb to develop immunotherapies
Dragonfly Therapeutics has entered into a research collaboration with Bristol Myers Squibb to discover and develop novel immunotherapies for multiple sclerosis and neuroinflammatory targets.
SiO2 increases vial capacity for COVID-19 vaccines
Advanced materials company SiO2 Materials Science has increased the manufacturing capacity of its plastic medical-grade vials to help meet the demand for COVID-19 vaccines.
Hansa licenses enzyme pretreatment for gene therapy
Hansa Biopharma has entered into an agreement with Sarepta Therapeutics for an exclusive worldwide license to develop and promote imlifidase as a pretreatment for gene therapy treatment of Duchenne muscular dystrophy and limb-girdle muscular dystrophy.
Inimmune gets grant for vaccine technology
Montana-based Inimmune received a $2 million grant from the U.S. National Institute for Allergy and Infectious Diseases to develop novel adjuvant and delivery systems for vaccines.
Faster fluid mixing could reduce costs for silica microparticles
A surprisingly simple approach to manufacturing silica nanoparticles by taking advantage of fluid dynamics in tiny Teflon tubes could reduce manufacturing costs. The work is described in a June 28 article published in the Chemical Engineering Journal.  Discuss
Luminex rolls out biological test platform to partners
Luminex has delivered the xMap Intelliflex system, a new version of its multiplexed biological test platform, to several life science partners.
New labs being built in Philadelphia due to gene, cell therapy demand
Real estate developer MRA Group is building lab spaces in Philadelphia to meet the region's growing demand for cell and gene therapy.
J&J's Ebola vaccine approved by EU
Johnson & Johnson announced that the European Commission granted marketing authorization for its Janssen Pharmaceutical Ebola vaccine regimen for the prevention of Ebola virus disease.
Lysogene partners with Weizmann Institute
Lysogene has inked a research agreement with Yeda Research and Development, the commercial arm of the Weizmann Institute of Science, for novel gene therapy.
Conferences
BioProcess International Europe
July 13-17
Central European Time Zone (CET) Netherlands
2020 ACCP Annual Meeting
September 20-22
Bethesda, Maryland United States
Bioprocess International West
September 21-24
Eastern Standard Time Zone (EST) United States
General Discussion
Topic Replies / Views Last Update
https://academic.oup.com/ve/pages/coronavirus-evolution
by Michael
0 / 47 More than 3 days ago
by Michael
PopSci Hails Impossible Burger 2.0 as Most Important Engineering Innovation in 2019
by Mahesh Gupta
0 / 14 More than 3 days ago
by Mahesh Gupta
Engineered Bacteria Produces BeeFree Honey
by Mahesh Gupta
0 / 12 More than 3 days ago
by Mahesh Gupta
Consumers' Preference to Buy Unlabeled Produce Increases after Exposure to GMO-labeled Pro
by Mahesh Gupta
0 / 15 More than 3 days ago
by Mahesh Gupta
Super-precise new CRISPR tool could tackle a plethora of genetic diseases
by Mahesh Gupta
0 / 14 More than 3 days ago
by Mahesh Gupta
To see more posts from our community or to share a post of your own, go to our community's forum page.
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter